864373151	864373151	CD	B-NP	O
|	|	NN	I-NP	O
RMMC	RMMC	NN	I-NP	O
|	|	NN	I-NP	O
63077749	63077749	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2825894	2825894	CD	B-NP	O
|	|	CC	I-NP	O
9/29/2005	9/29/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CELLULITIS	CELLULITIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/22/2005	1/22/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/26/2005	10/26/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
MUCZYNSKI	MUCZYNSKI	NNP	B-NP	O
,	,	,	O	O
CODY	CODY	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Prepatellar	Prepatellar	JJ	B-NP	O
bursitis	bursitis	NN	I-NP	O
versus	versus	IN	B-PP	O
prepatellar	prepatellar	JJ	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
with	with	IN	B-PP	O
bursitis	bursitis	NN	B-NP	O
.	.	.	O	O

SECONDARY	SECONDARY	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Peripheral	Peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
sepsis	sepsis	NN	B-NP	O
from	from	IN	B-PP	O
right	right	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Right	Right	RB	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	I-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
right	right	JJ	B-NP	O
knee	knee	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
68-year-old	68-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
PVD	PVD	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
right	right	RB	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	I-NP	O
pain	pain	NN	I-NP	O
progressing	progress	VBG	B-VP	O
over	over	IN	B-PP	O
four	four	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
for	for	IN	B-PP	O
questionable	questionable	JJ	B-NP	O
viral	viral	JJ	I-NP	O
gastroenteritis	gastroenteritis	NN	I-NP	O
and	and	CC	O	O
discharged	discharge	VBD	B-VP	O
four	four	CD	B-NP	O
days	day	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
increased	increase	VBN	I-VP	O
right	right	RB	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
erythema	erythema	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
for	for	IN	B-PP	O
presumed	presume	VBN	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

Actually	Actually	RB	B-ADVP	O
,	,	,	O	O
despite	despite	IN	B-PP	O
being	be	VBG	B-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
right	right	RB	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	I-NP	O
pain	pain	NN	I-NP	O
increased	increase	VBD	B-VP	O
over	over	IN	B-PP	O
four	four	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
became	become	VBD	B-VP	O
more	more	RBR	B-ADJP	O
painful	painful	JJ	I-ADJP	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
subjective	subjective	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
none	none	NN	B-NP	O
documented	document	VBN	B-VP	O
on	on	IN	B-PP	O
record	record	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
severe	severe	JJ	I-NP	O
pain	pain	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
patellar	patellar	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
hurts	hurt	VBZ	B-VP	O
to	to	TO	I-VP	O
flex	flex	VB	I-VP	O
and/or	and/or	CC	I-VP	O
bend	bend	VB	I-VP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
.	.	.	O	O

Baseline	Baseline	NNP	B-NP	O
right	right	RB	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
much	much	RB	B-ADJP	O
worse	worse	JJR	I-ADJP	O
than	than	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
prior	prior	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
pain	pain	NN	B-NP	O
in	in	IN	B-PP	O
calf	calf	NN	B-NP	O
or	or	CC	I-NP	O
thigh	thigh	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Wife	Wife	NNP	B-NP	O
provides	provide	VBZ	B-VP	O
daily	daily	RB	B-NP	O
diabetic	diabetic	JJ	I-NP	O
foot	foot	NN	I-NP	O
care	care	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
recurrent	recurrent	JJ	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
none	none	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
year	year	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
trauma	trauma	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
small	small	JJ	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
effusion	effusion	NN	I-NP	O
was	be	VBD	B-VP	O
tapped	tap	VBN	I-VP	O
by	by	IN	B-PP	O
ortho	ortho	JJ	B-NP	O
and	and	CC	I-NP	O
fluid	fluid	NN	I-NP	O
sent	send	VBN	B-VP	O
to	to	TO	B-VP	O
lab	lab	VB	I-VP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
bloody	bloody	JJ	B-ADJP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
growth	growth	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
given	give	VBN	I-VP	O
vancomycin	vancomycin	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Includes	Include	VBZ	B-VP	O
PVD	PVD	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
diabetic	diabetic	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
type	type	NN	I-NP	O
II	II	CD	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
status	status	NN	I-NP	I-protein
post	post	NN	I-NP	I-protein
CABG	CABG	NN	I-NP	I-protein
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
sepsis	sepsis	NN	B-NP	O
from	from	IN	B-PP	O
right	right	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
right	right	JJ	B-NP	O
femoral-peroneal	femoral-peroneal	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Carbamazepine	Carbamazepine	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
NovoLog	NovoLog	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
a.c.	a.c.	NN	I-NP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Avandia	Avandia	NNP	B-NP	O
8	8	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Prilosec	Prilosec	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
NPH	NPH	NN	B-NP	O
insulin	insulin	NN	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
subcu	subcu	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
SOCIAL	SOCIAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
adult	adult	JJ	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Sister	Sister	NN	B-NP	O
with	with	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
and	and	CC	I-NP	O
CAD	CAD	NN	I-NP	B-protein
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
97.5	97.5	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
of	of	IN	B-PP	O
84	84	CD	B-NP	O
,	,	,	O	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
137	137	CD	B-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hard	hard	JJ	B-ADJP	O
of	of	IN	B-PP	O
hearing	hearing	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
otherwise	otherwise	RB	B-ADVP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
CTAB	CTAB	NN	B-NP	B-protein
with	with	IN	B-PP	O
no	no	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

S1	S1	NN	B-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
S3	S3	NN	I-NP	B-protein
or	or	CC	I-NP	O
S4	S4	NN	I-NP	B-protein
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
and	and	CC	O	O
no	no	DT	B-NP	O
audible	audible	JJ	I-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
truncal	truncal	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
on	on	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
exam	exam	NN	I-NP	O
with	with	IN	B-PP	O
ventral	ventral	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
.	.	.	O	O

Nontender	Nontender	JJ	B-NP	O
and	and	CC	I-NP	O
active	active	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
had	have	VBD	B-VP	O
edema	edema	NN	B-NP	O
two	two	CD	B-NP	O
times	time	NNS	I-NP	O
the	the	DT	I-NP	O
size	size	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
x	x	SYM	I-NP	O
10	10	CD	I-NP	O
cm	cm	NN	I-NP	O
patch	patch	NN	I-NP	O
of	of	IN	B-PP	O
pink	pink	JJ	B-NP	O
erythematous	erythematous	JJ	I-NP	O
and	and	CC	I-NP	O
induration	induration	NN	I-NP	O
of	of	IN	B-PP	O
warmth	warmth	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
,	,	,	O	O
exquisitely	exquisitely	RB	B-NP	O
tender	tender	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
patellar	patellar	NN	I-NP	O
with	with	IN	B-PP	O
small	small	JJ	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
induration	induration	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
patella	patella	NN	I-NP	O
.	.	.	O	O

Nontender	Nontender	JJ	B-NP	B-cell_line
long	long	JJ	I-NP	I-cell_line
joint	joint	JJ	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
small	small	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pain	pain	NN	B-NP	O
with	with	IN	B-PP	O
passive	passive	JJ	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
motion	motion	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
patellar	patellar	JJ	I-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

Feet	Feet	NNP	B-NP	O
were	be	VBD	B-VP	O
clean	clean	JJ	B-ADJP	O
without	without	IN	B-PP	O
cracking	cracking	NN	B-NP	O
,	,	,	O	O
maceration	maceration	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
ulcers	ulcer	NNS	B-NP	O
.	.	.	O	O

PERTINENT	PERTINENT	NN	B-NP	O
LABS	LABS	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Creatinine	Creatinine	NN	B-NP	O
of	of	IN	B-PP	O
2.3	2.3	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
74	74	CD	B-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
of	of	IN	B-PP	O
119	119	CD	B-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
and	and	CC	I-NP	O
potassium	potassium	NN	I-NP	O
of	of	IN	B-PP	O
136	136	CD	B-NP	O
and	and	CC	I-NP	O
4.3	4.3	CD	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
8.7	8.7	CD	B-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
differential	differential	JJ	I-NP	O
,	,	,	O	O
78	78	CD	B-NP	O
%	%	NN	I-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
34.1	34.1	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
298	298	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
1.0	1.0	CD	B-NP	O
.	.	.	O	O

ESR	ESR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
98	98	CD	B-NP	O
.	.	.	O	O

Uric	Uric	JJ	B-NP	O
acid	acid	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Synovial	Synovial	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
crystals	crystal	NNS	B-NP	O
and	and	CC	O	O
gram-stain	gram-stain	NN	B-NP	B-protein
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

LENI	LENI	NNP	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
right	right	RB	B-ADVP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
DVT	DVT	NN	B-NP	O
above	above	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Musculoskeletal/ID/Rheum	Musculoskeletal/ID/Rheum	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
right	right	JJ	B-NP	O
knee	knee	NN	I-NP	O
prepatellar	prepatellar	JJ	I-NP	O
bursitis	bursitis	NN	I-NP	O
versus	versus	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
plain	plain	JJ	B-NP	O
film	film	NN	I-NP	O
and	and	CC	I-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
,	,	,	O	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
any	any	DT	B-NP	O
large	large	JJ	I-NP	O
prepatellar	prepatellar	JJ	I-NP	O
bursal	bursal	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
other	other	JJ	I-NP	O
trauma	trauma	NN	I-NP	O
or	or	CC	I-NP	O
fracture	fracture	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
seen	see	VBN	I-VP	O
on	on	IN	B-PP	O
x-ray	x-ray	NN	B-NP	B-DNA
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
doing	do	VBG	I-VP	O
well	well	RB	B-ADJP	O
in-house	in-house	JJ	I-ADJP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
erythema	erythema	NN	I-NP	O
and	and	CC	I-NP	O
pain	pain	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
respond	respond	VB	I-VP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
and	and	CC	I-NP	O
p.o.	p.o.	NN	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
at	at	IN	B-PP	O
renal	renal	JJ	B-NP	O
dosing	dosing	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
by	by	IN	B-PP	O
rheumatology	rheumatology	NN	B-NP	O
who	who	WP	B-NP	O
graciously	graciously	RB	B-VP	O
consulted	consult	VBD	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
likely	likely	JJ	I-NP	O
prepatellar	prepatellar	JJ	I-NP	O
bursitis	bursitis	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
possible	possible	JJ	B-ADJP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
overlying	overlie	VBG	B-VP	O
the	the	DT	B-NP	O
prepatellar	prepatellar	JJ	I-NP	O
area	area	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
joint	joint	JJ	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Tap	Tap	NN	B-NP	B-protein
on	on	IN	B-PP	O
11/7/05	11/7/05	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
prepatellar	prepatellar	JJ	I-NP	O
bursal	bursal	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
crystals	crystal	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
polynuclear	polynuclear	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
organisms	organism	NNS	I-NP	O
were	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
again	again	RB	B-ADVP	O
,	,	,	O	O
prepatellar	prepatellar	JJ	B-NP	O
bursitis	bursitis	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
did	do	VBD	B-VP	O
slowly	slowly	RB	I-VP	O
resolve	resolve	VB	I-VP	O
while	while	IN	B-SBAR	O
inhouse	inhouse	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
bend	bend	VB	I-VP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
and	and	CC	O	O
do	do	VB	B-VP	O
weightbearing	weightbearing	NN	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
with	with	IN	B-PP	O
pain	pain	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
infection	infection	NN	I-NP	O
or	or	CC	I-NP	O
sepsis	sepsis	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
Rheumatology	Rheumatology	NNP	B-NP	O
suggested	suggest	VBD	B-VP	O
starting	start	VBG	I-VP	O
colchicine	colchicine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
0.6	0.6	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
0.6	0.6	CD	I-NP	O
mg	mg	NN	I-NP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Wamai	Wamai	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
prepatellar	prepatellar	JJ	B-NP	O
bursitis	bursitis	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
uric	uric	JJ	B-NP	O
acid	acid	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
normal	normal	JJ	B-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
joint	joint	NN	B-NP	O
infection	infection	NN	I-NP	O
or	or	CC	O	O
spreading	spread	VBG	B-VP	O
fascial	fascial	JJ	B-NP	O
infection	infection	NN	I-NP	O
or	or	CC	O	O
worsening	worsen	VBG	B-VP	O
cellulitis	cellulitis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Keflex	Keflex	NNP	B-NP	O
despite	despite	IN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
respond	respond	VB	I-VP	O
to	to	TO	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	RB	B-ADJP	O
a	a	DT	B-NP	O
prepatellar	prepatellar	JJ	I-NP	O
bursitis	bursitis	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
case	case	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
small	small	JJ	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
Keflex	Keflex	NNP	I-NP	O
at	at	IN	B-PP	O
renal	renal	JJ	B-NP	O
dose	dose	NN	I-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Way	Way	NNP	B-NP	O
Oa	Oa	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
not	not	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
NPH	NPH	NN	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
and	and	CC	O	O
required	require	VBD	B-VP	O
increased	increase	VBN	I-VP	O
NovoLog	NovoLog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
standing	standing	NN	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
plus	plus	CC	O	O
sliding	slide	VBG	B-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
after	after	IN	B-PP	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
ranged	range	VBD	B-VP	O
from	from	IN	B-PP	O
90s	90s	CD	B-NP	O
to	to	TO	B-PP	O
180s	180s	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
far	far	RB	I-VP	O
improved	improve	VBN	I-VP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
sugars	sugar	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
300s	300	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	B-protein
dose	dose	NN	I-NP	I-protein
NPH	NPH	NN	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
NovoLog	NovoLog	NNP	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
oral	oral	JJ	B-NP	O
Avandia	Avandia	NNP	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Pain	Pain	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
two	two	CD	I-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
times	time	NNS	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Vascular	Vascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
full	full	JJ	B-NP	O
LENI	LENI	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
any	any	DT	B-NP	O
thrombus	thrombus	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
on	on	IN	B-PP	O
LENI	LENI	NN	B-NP	B-protein
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
looks	look	VBZ	B-VP	O
like	like	IN	B-PP	O
acute	acute	JJ	B-NP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-ADJP	O
given	give	VBN	B-PP	O
for	for	IN	B-PP	O
unknown	unknown	JJ	B-NP	O
reasons	reason	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
b.i.d.	b.i.d.	NNP	I-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	I-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1.9	1.9	CD	I-NP	O
to	to	TO	B-PP	O
2.2	2.2	CD	B-NP	O
.	.	.	O	O

Discharge	Discharge	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
2.0	2.0	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
by	by	IN	B-PP	O
Villerich	Villerich	NNP	B-NP	O
Deo	Deo	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
seems	seem	VBZ	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
from	from	IN	B-PP	O
long-standing	long-standing	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
without	without	IN	B-PP	O
a	a	DT	B-NP	O
severe	severe	JJ	I-NP	O
acute	acute	JJ	I-NP	O
component	component	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
prophylactic	prophylactic	JJ	B-NP	O
Lovenox	Lovenox	NN	I-NP	O
and	and	CC	I-NP	O
Nexium	Nexium	NN	I-NP	O
while	while	IN	B-SBAR	O
in-house	in-house	NN	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
Keflex	Keflex	NN	I-NP	O
and	and	CC	I-NP	O
colchicine	colchicine	NN	I-NP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Diabetic	Diabetic	JJ	B-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
calorie	calorie	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
saturated	saturate	VBN	I-NP	O
fat	fat	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
low-cholesterol	low-cholesterol	NN	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Walking	Walk	VBG	B-VP	O
,	,	,	O	O
with	with	IN	B-PP	O
weightbearing	weightbearing	NN	B-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

Elevate	Elevate	JJ	B-NP	O
legs	leg	NNS	I-NP	O
and	and	CC	I-NP	O
knees	knee	NNS	I-NP	O
with	with	IN	B-PP	O
prolonged	prolonged	JJ	B-NP	O
sitting	sit	VBG	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Include	Include	VB	B-VP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
,	,	,	O	O
fish	fish	NN	B-NP	O
oil	oil	NN	I-NP	O
capsule	capsule	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Avandia	Avandia	NNP	B-NP	O
8	8	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
carbamazepine	carbamazepine	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Novolin	Novolin	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
tartrate	tartrate	NN	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
Keflex	Keflex	NNP	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-NP	O
x10	x10	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
from	from	IN	B-PP	O
now	now	RB	B-ADVP	O
on	on	IN	B-PP	O
given	give	VBN	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
Avalide	Avalide	NNP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
held	hold	VBN	I-VP	O
until	until	IN	B-PP	O
future	future	JJ	B-NP	O
notice	notice	NN	I-NP	O
,	,	,	O	O
Novolin	Novolin	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
to	to	TO	I-NP	O
10	10	CD	I-NP	O
units	unit	NNS	I-NP	O
before	before	IN	B-PP	O
breakfast	breakfast	NN	B-NP	O
and	and	CC	I-NP	O
dinner	dinner	NN	I-NP	O
,	,	,	O	O
Prilosec	Prilosec	NNP	B-NP	O
OTC	OTC	NNP	I-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
colchicine	colchicine	NN	B-NP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	IN	B-PP	O
0.6	0.6	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
0.6	0.6	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
seven	seven	CD	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
colchicine	colchicine	NN	B-NP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	NN	B-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
receive	receive	VB	I-VP	O
eight	eight	CD	B-NP	O
tablets	tablet	NNS	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
control	control	NN	I-NP	O
and	and	CC	O	O
four	four	CD	B-NP	O
tablets	tablet	NNS	I-NP	O
of	of	IN	B-PP	O
Ativan	Ativan	NNP	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
again	again	RB	B-ADVP	O
four	four	CD	B-NP	O
pills	pill	NNS	I-NP	O
only	only	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
9-8711816	9-8711816	CD	B-NP	O
EMSFocus	EMSFocus	NN	I-NP	O
transcriptionists	transcriptionist	NNS	I-NP	O
Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
STEADHAM	STEADHAM	NN	B-NP	O
,	,	,	O	O
DEVON	DEVON	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SAMYN	SAMYN	NNP	B-NP	O
,	,	,	O	O
RUSSEL	RUSSEL	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
9690176	9690176	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
4/30/05	4/30/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
4/30/05	4/30/05	CD	B-NP	O

